Resurge Therapeutics Inc.
Resurge Therapeutics Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RT-310 Safety and Feasibility BPH Study | Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-20 | NCT07264205 | |
| RT-310 Dose Escalation BPH Study | Genital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder | Active, not recruiting | Phase 1 | 2025-11-28 | NCT06136819 |